Monte Rosa Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Monte Rosa Therapeutics generated cash of -$43,802,000, which is more than the previous year. Cash used in financing activities reached the amount of $27,492,000 last year. Net change in cash is therefore $72,491,000.
Cash Flow
| 2019 | -6.17M | -1.38M | 15M |
|---|---|---|---|
| 2020 | -23.05M | -3.38M | 60.06M |
| 2021 | -59.36M | -9.65M | 377.56M |
| 2022 | -92.46M | -219.21M | 20.46M |
| 2023 | -43.80M | 88.80M | 27.49M |
GLUE Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 60.19M | 351.40M | 42.86M | 9.24M | 1.80M |
Operating activities | |||||
Net income | -135.35M | -108.50M | -73.95M | -35.87M | -7.74M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 6.22M | 3.74M | 2.13M | 537K | 72K |
Stock-based compensation expense | 16.66M | 11.66M | 5.2M | 354K | 0 |
| Deferred income tax benefit | 16.66M | 11.66M | 5.2M | 354K | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 1.89M | -187 | 0 | 0 | 0 |
Inventories | 0 | 187 | 0 | 0 | 0 |
Accounts payable | 5.75M | -744K | -706K | 3.43M | 2.86M |
Cash generated by operating activities | -43.80M | -92.46M | -59.36M | -23.05M | -6.17M |
Investing activities | |||||
Purchases Of Investments | -103.15M | -384.41M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -19.04M | -12.91M | -9.73M | -3.38M | -1.38M |
Acquisitions Net | 0 | 109K | 79K | 0 | 0 |
Cash generated by investing activities | 88.80M | -219.21M | -9.65M | -3.38M | -1.38M |
Financing activities | |||||
Common Stock Issued | 27.49M | 20.05M | 377.56M | 60.06M | 14.25M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -440K | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 750K |
Cash used in financing activities | 27.49M | 20.46M | 377.56M | 60.06M | 15M |
Net Change In Cash | 72.49M | -291.21M | 308.54M | 33.61M | 7.44M |
Cash at end of period | 132.68M | 60.19M | 351.40M | 42.86M | 9.24M |
| Data source | Data source | Data source |